McClarren Financial Advisors Inc. Has $188,000 Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

McClarren Financial Advisors Inc. grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 73.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 356 shares of the healthcare conglomerate’s stock after purchasing an additional 151 shares during the period. McClarren Financial Advisors Inc.’s holdings in UnitedHealth Group were worth $188,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the company. Robbins Farley acquired a new stake in shares of UnitedHealth Group during the third quarter worth $25,000. Richelieu Gestion SA bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $26,000. CGC Financial Services LLC grew its holdings in shares of UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 50 shares in the last quarter. NewSquare Capital LLC boosted its position in UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA raised its holdings in shares of UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have issued reports on UNH. Stephens reiterated an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 8th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Morgan Stanley reduced their price target on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Wells Fargo & Company cut their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Finally, Bank of America restated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a research note on Thursday, March 7th. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded up $6.58 during mid-day trading on Thursday, reaching $493.88. The company had a trading volume of 4,329,383 shares, compared to its average volume of 4,530,458. The firm has a market cap of $454.41 billion, a price-to-earnings ratio of 30.19, a PEG ratio of 1.41 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The business’s 50-day simple moving average is $486.36 and its 200 day simple moving average is $514.42.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the prior year, the firm posted $6.26 EPS. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. On average, research analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.